Geneoscopy CEO Talks its FDA Approved Colorectal Cancer Screening Test ColoSense
Floor Talk
•
4m 44s
Andrew Barnell of Geneoscopy joins Kristen Scholer on NYSE Floor Talk to discuss the FDA Approved Colorectal Cancer Screening Test Called ColoSense
Up Next in Floor Talk
-
InMarket CEO on its trends shaping th...
Todd Morris, CEO of InMarket, joins #NYSEFloorTalk with Judy Khan Shaw to discuss InMarket's unique edge in engaging with top U.S. brands and the latest trends shaping the marketing landscape.
-
The Cigna Group's Brian Evanko on how...
Brian Evanko, President & COO of The Cigna Group, joined Judy Khan Shaw on #NYSEFloorTalk to discuss how the company is working to enhance customer experiences, address industry challenges, and improve health outcomes in 2025 and beyond.
-
David Eckstein, CFO of Vanta, celebra...
David Eckstein, CFO of Vanta, celebrates reaching $100M ARR and shares insights on their role in internet security, new AI offerings, and Vanta's growth on #NYSEFloorTalk with Judy Khan Shaw.
